INV-082 · Money & ethics · Family business
Trump sons' fund and federal Ebola screening contracts for XpresTest
Stage 1 of 5: Reported · News reporting only · Last development 9 Nov 2026
ProPublica reports that XpresTest, a subsidiary of XWELL, received a CDC contract for Ebola entry screening and a State Department award for the Congo outbreak response in 2026, after a fund launched by Dominari Holdings, in which Donald Trump Jr. and Eric Trump hold a stake of more than 10%, invested in XWELL.
Reported by ProPublica; no official inquiry or finding so far. The companies and the State Department say the awards were competitive. Amounts are listed separately.


- People
- Donald Trump Jr., Eric Trump, XpresTest, Dominari Holdings
- Agencies
- HHS (CDC), State Dept
- Reviewed by
- Press
Follow this case
See the cases you follow, and which have news, on Following. Or get each update in a feed reader or by email: feed for this case (how).
Money involved
- $18.8 million CDC contract to XpresTest for Ebola entry screening (Taxpayer money in questioned contracts, loans and funds) [1]
- $20 million State Department award to XpresTest for the Congo Ebola response (Taxpayer money in questioned contracts, loans and funds, estimate) [1]
- $30 million Dominari-launched fund's reported investment in XWELL, XpresTest's parent, not a payment to the Trumps (Other amounts, not totaled, estimate) [1]
Timeline
ProPublica reports the two awards and the Dominari fund's investment in XWELL. The CDC did not respond to ProPublica. [1]
The State Department awards XpresTest about $20 million for the response to the Ebola outbreak in the Democratic Republic of Congo. [1]
The CDC awards XpresTest an $18.8 million contract for "Ebola entry screening services". [1]
American Ventures, a fund launched by Dominari Holdings, invests about $30 million in XWELL, the parent company of XpresTest. Donald Trump Jr. and Eric Trump are advisers to Dominari and hold a stake of more than 10% in it. [1]
Responses
- Spokesperson for Donald Trump Jr. and Eric Trump: They are "merely passive, minority investors in a fund that invested in this company" and had no "involvement in or knowledge regarding the negotiation or procurement of any of its contracts." [1]
- State Department: The award was made "through a competitive process that builds on this successful model." [1]
- Dominari CEO Anthony Hayes: "We have never seen or even heard of Don or Eric using their family name to influence" government contracts. [1]
Sources
Cite this case
Public Trust Tracker. "Trump sons' fund and federal Ebola screening contracts for XpresTest" (INV-082). Last updated 9 Nov 2026. https://publictrusttracker.org/case/inv-082-trump-sons-fund-and-federal-ebola-screening-contracts-for/
Suggest a fact check